The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chickenpox (Varicella) Vaccine Market Research Report 2025
Synopsis
The global Chickenpox (Varicella) Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chickenpox (Varicella) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chickenpox (Varicella) Vaccine.
Report Scope
The Chickenpox (Varicella) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chickenpox (Varicella) Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chickenpox (Varicella) Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co.
Sanofi Pasteur
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
Segment by Type
Monovalent Vaccine
Combination Vaccine
Segment by Application
Kids Injection
Adults Injection
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chickenpox (Varicella) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chickenpox (Varicella) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Chickenpox (Varicella) Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chickenpox (Varicella) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chickenpox (Varicella) Vaccine.
Report Scope
The Chickenpox (Varicella) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chickenpox (Varicella) Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chickenpox (Varicella) Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck & Co.
Sanofi Pasteur
GSK
Shanghai Institute
BCHT
Changsheng
Keygen
Green Cross
Biken
Segment by Type
Monovalent Vaccine
Combination Vaccine
Segment by Application
Kids Injection
Adults Injection
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chickenpox (Varicella) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chickenpox (Varicella) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Chickenpox (Varicella) Vaccine Market Overview
1.1 Product Overview and Scope of Chickenpox (Varicella) Vaccine
1.2 Chickenpox (Varicella) Vaccine Segment by Type
1.2.1 Global Chickenpox (Varicella) Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Monovalent Vaccine
1.2.3 Combination Vaccine
1.3 Chickenpox (Varicella) Vaccine Segment by Application
1.3.1 Global Chickenpox (Varicella) Vaccine Market Value by Application: (2024-2030)
1.3.2 Kids Injection
1.3.3 Adults Injection
1.4 Global Chickenpox (Varicella) Vaccine Market Size Estimates and Forecasts
1.4.1 Global Chickenpox (Varicella) Vaccine Revenue 2019-2030
1.4.2 Global Chickenpox (Varicella) Vaccine Sales 2019-2030
1.4.3 Global Chickenpox (Varicella) Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Chickenpox (Varicella) Vaccine Market Competition by Manufacturers
2.1 Global Chickenpox (Varicella) Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Chickenpox (Varicella) Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Chickenpox (Varicella) Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Chickenpox (Varicella) Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Chickenpox (Varicella) Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Chickenpox (Varicella) Vaccine, Product Type & Application
2.7 Chickenpox (Varicella) Vaccine Market Competitive Situation and Trends
2.7.1 Chickenpox (Varicella) Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Chickenpox (Varicella) Vaccine Players Market Share by Revenue
2.7.3 Global Chickenpox (Varicella) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Chickenpox (Varicella) Vaccine Retrospective Market Scenario by Region
3.1 Global Chickenpox (Varicella) Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Chickenpox (Varicella) Vaccine Global Chickenpox (Varicella) Vaccine Sales by Region: 2019-2030
3.2.1 Global Chickenpox (Varicella) Vaccine Sales by Region: 2019-2024
3.2.2 Global Chickenpox (Varicella) Vaccine Sales by Region: 2025-2030
3.3 Global Chickenpox (Varicella) Vaccine Global Chickenpox (Varicella) Vaccine Revenue by Region: 2019-2030
3.3.1 Global Chickenpox (Varicella) Vaccine Revenue by Region: 2019-2024
3.3.2 Global Chickenpox (Varicella) Vaccine Revenue by Region: 2025-2030
3.4 North America Chickenpox (Varicella) Vaccine Market Facts & Figures by Country
3.4.1 North America Chickenpox (Varicella) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Chickenpox (Varicella) Vaccine Sales by Country (2019-2030)
3.4.3 North America Chickenpox (Varicella) Vaccine Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Chickenpox (Varicella) Vaccine Market Facts & Figures by Country
3.5.1 Europe Chickenpox (Varicella) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Chickenpox (Varicella) Vaccine Sales by Country (2019-2030)
3.5.3 Europe Chickenpox (Varicella) Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Chickenpox (Varicella) Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Chickenpox (Varicella) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Chickenpox (Varicella) Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Chickenpox (Varicella) Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Chickenpox (Varicella) Vaccine Market Facts & Figures by Country
3.7.1 Latin America Chickenpox (Varicella) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Chickenpox (Varicella) Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Chickenpox (Varicella) Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Chickenpox (Varicella) Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Chickenpox (Varicella) Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Chickenpox (Varicella) Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Chickenpox (Varicella) Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Chickenpox (Varicella) Vaccine Sales by Type (2019-2030)
4.1.1 Global Chickenpox (Varicella) Vaccine Sales by Type (2019-2024)
4.1.2 Global Chickenpox (Varicella) Vaccine Sales by Type (2025-2030)
4.1.3 Global Chickenpox (Varicella) Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Chickenpox (Varicella) Vaccine Revenue by Type (2019-2030)
4.2.1 Global Chickenpox (Varicella) Vaccine Revenue by Type (2019-2024)
4.2.2 Global Chickenpox (Varicella) Vaccine Revenue by Type (2025-2030)
4.2.3 Global Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Chickenpox (Varicella) Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Chickenpox (Varicella) Vaccine Sales by Application (2019-2030)
5.1.1 Global Chickenpox (Varicella) Vaccine Sales by Application (2019-2024)
5.1.2 Global Chickenpox (Varicella) Vaccine Sales by Application (2025-2030)
5.1.3 Global Chickenpox (Varicella) Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Chickenpox (Varicella) Vaccine Revenue by Application (2019-2030)
5.2.1 Global Chickenpox (Varicella) Vaccine Revenue by Application (2019-2024)
5.2.2 Global Chickenpox (Varicella) Vaccine Revenue by Application (2025-2030)
5.2.3 Global Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Chickenpox (Varicella) Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck & Co.
6.1.1 Merck & Co. Corporation Information
6.1.2 Merck & Co. Description and Business Overview
6.1.3 Merck & Co. Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck & Co. Chickenpox (Varicella) Vaccine Product Portfolio
6.1.5 Merck & Co. Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Pasteur Chickenpox (Varicella) Vaccine Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Chickenpox (Varicella) Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Shanghai Institute
6.4.1 Shanghai Institute Corporation Information
6.4.2 Shanghai Institute Description and Business Overview
6.4.3 Shanghai Institute Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shanghai Institute Chickenpox (Varicella) Vaccine Product Portfolio
6.4.5 Shanghai Institute Recent Developments/Updates
6.5 BCHT
6.5.1 BCHT Corporation Information
6.5.2 BCHT Description and Business Overview
6.5.3 BCHT Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 BCHT Chickenpox (Varicella) Vaccine Product Portfolio
6.5.5 BCHT Recent Developments/Updates
6.6 Changsheng
6.6.1 Changsheng Corporation Information
6.6.2 Changsheng Description and Business Overview
6.6.3 Changsheng Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Changsheng Chickenpox (Varicella) Vaccine Product Portfolio
6.6.5 Changsheng Recent Developments/Updates
6.7 Keygen
6.6.1 Keygen Corporation Information
6.6.2 Keygen Description and Business Overview
6.6.3 Keygen Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Keygen Chickenpox (Varicella) Vaccine Product Portfolio
6.7.5 Keygen Recent Developments/Updates
6.8 Green Cross
6.8.1 Green Cross Corporation Information
6.8.2 Green Cross Description and Business Overview
6.8.3 Green Cross Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Green Cross Chickenpox (Varicella) Vaccine Product Portfolio
6.8.5 Green Cross Recent Developments/Updates
6.9 Biken
6.9.1 Biken Corporation Information
6.9.2 Biken Description and Business Overview
6.9.3 Biken Chickenpox (Varicella) Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biken Chickenpox (Varicella) Vaccine Product Portfolio
6.9.5 Biken Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Chickenpox (Varicella) Vaccine Industry Chain Analysis
7.2 Chickenpox (Varicella) Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Chickenpox (Varicella) Vaccine Production Mode & Process
7.4 Chickenpox (Varicella) Vaccine Sales and Marketing
7.4.1 Chickenpox (Varicella) Vaccine Sales Channels
7.4.2 Chickenpox (Varicella) Vaccine Distributors
7.5 Chickenpox (Varicella) Vaccine Customers
8 Chickenpox (Varicella) Vaccine Market Dynamics
8.1 Chickenpox (Varicella) Vaccine Industry Trends
8.2 Chickenpox (Varicella) Vaccine Market Drivers
8.3 Chickenpox (Varicella) Vaccine Market Challenges
8.4 Chickenpox (Varicella) Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Chickenpox (Varicella) Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Chickenpox (Varicella) Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Chickenpox (Varicella) Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Chickenpox (Varicella) Vaccine Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Chickenpox (Varicella) Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Chickenpox (Varicella) Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Chickenpox (Varicella) Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Chickenpox (Varicella) Vaccine Average Price (USD/dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Chickenpox (Varicella) Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Chickenpox (Varicella) Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Chickenpox (Varicella) Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Chickenpox (Varicella) Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Chickenpox (Varicella) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chickenpox (Varicella) Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Chickenpox (Varicella) Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Chickenpox (Varicella) Vaccine Sales by Region (2019-2024) & (K Doses)
Table 18. Global Chickenpox (Varicella) Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Chickenpox (Varicella) Vaccine Sales by Region (2025-2030) & (K Doses)
Table 20. Global Chickenpox (Varicella) Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Chickenpox (Varicella) Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Chickenpox (Varicella) Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Chickenpox (Varicella) Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Chickenpox (Varicella) Vaccine Sales by Country (2019-2024) & (K Doses)
Table 27. North America Chickenpox (Varicella) Vaccine Sales by Country (2025-2030) & (K Doses)
Table 28. North America Chickenpox (Varicella) Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Chickenpox (Varicella) Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Chickenpox (Varicella) Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Chickenpox (Varicella) Vaccine Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Chickenpox (Varicella) Vaccine Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Chickenpox (Varicella) Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Chickenpox (Varicella) Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Chickenpox (Varicella) Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Chickenpox (Varicella) Vaccine Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Chickenpox (Varicella) Vaccine Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Chickenpox (Varicella) Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Chickenpox (Varicella) Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Chickenpox (Varicella) Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Chickenpox (Varicella) Vaccine Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Chickenpox (Varicella) Vaccine Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Chickenpox (Varicella) Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Chickenpox (Varicella) Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Chickenpox (Varicella) Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Chickenpox (Varicella) Vaccine Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Chickenpox (Varicella) Vaccine Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Chickenpox (Varicella) Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Chickenpox (Varicella) Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2019-2024)
Table 51. Global Chickenpox (Varicella) Vaccine Sales (K Doses) by Type (2025-2030)
Table 52. Global Chickenpox (Varicella) Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Chickenpox (Varicella) Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Chickenpox (Varicella) Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Chickenpox (Varicella) Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Chickenpox (Varicella) Vaccine Price (USD/dose) by Type (2019-2024)
Table 59. Global Chickenpox (Varicella) Vaccine Price (USD/dose) by Type (2025-2030)
Table 60. Global Chickenpox (Varicella) Vaccine Sales (K Doses) by Application (2019-2024)
Table 61. Global Chickenpox (Varicella) Vaccine Sales (K Doses) by Application (2025-2030)
Table 62. Global Chickenpox (Varicella) Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Chickenpox (Varicella) Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Chickenpox (Varicella) Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Chickenpox (Varicella) Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Chickenpox (Varicella) Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Chickenpox (Varicella) Vaccine Price (USD/dose) by Application (2019-2024)
Table 69. Global Chickenpox (Varicella) Vaccine Price (USD/dose) by Application (2025-2030)
Table 70. Merck & Co. Corporation Information
Table 71. Merck & Co. Description and Business Overview
Table 72. Merck & Co. Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)
Table 73. Merck & Co. Chickenpox (Varicella) Vaccine Product
Table 74. Merck & Co. Recent Developments/Updates
Table 75. Sanofi Pasteur Corporation Information
Table 76. Sanofi Pasteur Description and Business Overview
Table 77. Sanofi Pasteur Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)
Table 78. Sanofi Pasteur Chickenpox (Varicella) Vaccine Product
Table 79. Sanofi Pasteur Recent Developments/Updates
Table 80. GSK Corporation Information
Table 81. GSK Description and Business Overview
Table 82. GSK Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)
Table 83. GSK Chickenpox (Varicella) Vaccine Product
Table 84. GSK Recent Developments/Updates
Table 85. Shanghai Institute Corporation Information
Table 86. Shanghai Institute Description and Business Overview
Table 87. Shanghai Institute Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)
Table 88. Shanghai Institute Chickenpox (Varicella) Vaccine Product
Table 89. Shanghai Institute Recent Developments/Updates
Table 90. BCHT Corporation Information
Table 91. BCHT Description and Business Overview
Table 92. BCHT Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)
Table 93. BCHT Chickenpox (Varicella) Vaccine Product
Table 94. BCHT Recent Developments/Updates
Table 95. Changsheng Corporation Information
Table 96. Changsheng Description and Business Overview
Table 97. Changsheng Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)
Table 98. Changsheng Chickenpox (Varicella) Vaccine Product
Table 99. Changsheng Recent Developments/Updates
Table 100. Keygen Corporation Information
Table 101. Keygen Description and Business Overview
Table 102. Keygen Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)
Table 103. Keygen Chickenpox (Varicella) Vaccine Product
Table 104. Keygen Recent Developments/Updates
Table 105. Green Cross Corporation Information
Table 106. Green Cross Description and Business Overview
Table 107. Green Cross Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)
Table 108. Green Cross Chickenpox (Varicella) Vaccine Product
Table 109. Green Cross Recent Developments/Updates
Table 110. Biken Corporation Information
Table 111. Biken Description and Business Overview
Table 112. Biken Chickenpox (Varicella) Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/dose) and Gross Margin (2019-2024)
Table 113. Biken Chickenpox (Varicella) Vaccine Product
Table 114. Biken Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Chickenpox (Varicella) Vaccine Distributors List
Table 118. Chickenpox (Varicella) Vaccine Customers List
Table 119. Chickenpox (Varicella) Vaccine Market Trends
Table 120. Chickenpox (Varicella) Vaccine Market Drivers
Table 121. Chickenpox (Varicella) Vaccine Market Challenges
Table 122. Chickenpox (Varicella) Vaccine Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Chickenpox (Varicella) Vaccine
Figure 2. Global Chickenpox (Varicella) Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Chickenpox (Varicella) Vaccine Market Share by Type in 2023 & 2030
Figure 4. Monovalent Vaccine Product Picture
Figure 5. Combination Vaccine Product Picture
Figure 6. Global Chickenpox (Varicella) Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Chickenpox (Varicella) Vaccine Market Share by Application in 2023 & 2030
Figure 8. Kids Injection
Figure 9. Adults Injection
Figure 10. Global Chickenpox (Varicella) Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Chickenpox (Varicella) Vaccine Market Size (2019-2030) & (US$ Million)
Figure 12. Global Chickenpox (Varicella) Vaccine Sales (2019-2030) & (K Doses)
Figure 13. Global Chickenpox (Varicella) Vaccine Average Price (USD/dose) & (2019-2030)
Figure 14. Chickenpox (Varicella) Vaccine Report Years Considered
Figure 15. Chickenpox (Varicella) Vaccine Sales Share by Manufacturers in 2023
Figure 16. Global Chickenpox (Varicella) Vaccine Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Chickenpox (Varicella) Vaccine Players: Market Share by Revenue in 2023
Figure 18. Chickenpox (Varicella) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Chickenpox (Varicella) Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Chickenpox (Varicella) Vaccine Sales Market Share by Country (2019-2030)
Figure 21. North America Chickenpox (Varicella) Vaccine Revenue Market Share by Country (2019-2030)
Figure 22. the United States Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Chickenpox (Varicella) Vaccine Sales Market Share by Country (2019-2030)
Figure 25. Europe Chickenpox (Varicella) Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. Germany Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. UK Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Chickenpox (Varicella) Vaccine Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Chickenpox (Varicella) Vaccine Revenue Market Share by Region (2019-2030)
Figure 33. China Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Chickenpox (Varicella) Vaccine Sales Market Share by Country (2019-2030)
Figure 43. Latin America Chickenpox (Varicella) Vaccine Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Chickenpox (Varicella) Vaccine Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Chickenpox (Varicella) Vaccine Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Chickenpox (Varicella) Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Chickenpox (Varicella) Vaccine by Type (2019-2030)
Figure 53. Global Revenue Market Share of Chickenpox (Varicella) Vaccine by Type (2019-2030)
Figure 54. Global Chickenpox (Varicella) Vaccine Price (USD/dose) by Type (2019-2030)
Figure 55. Global Sales Market Share of Chickenpox (Varicella) Vaccine by Application (2019-2030)
Figure 56. Global Revenue Market Share of Chickenpox (Varicella) Vaccine by Application (2019-2030)
Figure 57. Global Chickenpox (Varicella) Vaccine Price (USD/dose) by Application (2019-2030)
Figure 58. Chickenpox (Varicella) Vaccine Value Chain
Figure 59. Chickenpox (Varicella) Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
